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The 46,XX testicular disorder of sex development (46,XX testicu-
lar DSD) is a rare phenotype associated with disorder of the sex
chromosomes. We describe the clinical, molecular, and cytoge-
netic findings of a 16- and a 30-year-old male patient with
sex-determining region Y (SRY)-positive 46,XX testicular DSD.
Chromosomal analysis revealed 46,XX karyotype. Fluorescence
in situ hybridization (FISH) showed the SRY region translocated
to the short arm of the X chromosome. The presence of the
SRY gene was also confirmed by polymerase chain reaction
(PCR). The X chromosome inactivation (XCI) assay showed that
both patients have a random pattern of X chromosome inacti-
vation. This report compares the symptoms and features of
the SRY-positive 46,XX testicular DSD patients.
Keywords 46,XX Testicular DSD, mosaicism, SRY positive, XCI
Abbreviations 46,XX testicular DSD: 46,XX testicular disorder of
sex development; SRY: sex-determining region Y; FISH:
fluorescence in situ hybridization; PCR: polymerase chain
reaction; XCI: X chromosome inactivation; PARs:
pseudoautosomal regions; DXZ1: X centromere a-satellite
probe.
Introduction
46,XX testicular disorder of sex development [46,XX testicu-
lar DSD; 46,XX gonadal dysgenesis; XX male syndrome
(MIM 400045)] was described by De la Chapelle et al. in
1964 [De La Chapelle et al. 1964]. It is a rare disorder with
an incidence of 1/20,000 males [De La Chapelle 1981].
Approximately 80% of the cases are sex-determining
region Y (SRY)-positive, while the remaining cases are
SRY-negative [Vilain 2003]. The presentation includes
primary hypogonadism, small testes, gynecomastia, and
hyalinization of seminiferous tubules, azoospermia, and
infertility [Ergun-Longmire et al. 2005]. In this study, we
report the clinical, cytogenetical, fluorescence in situ hybrid-
ization (FISH), and molecular findings of two cases with
SRY-positive 46,XX testicular DSD.
Clinical Report
Patient I
A 30-year-old male was referred from Urology Clinic with a
five year history of male infertility. His wife had a healthy
child from her first marriage. He has two healthy fertile
brothers and one healthy sister. He presented a normal
male phenotype with short stature, relatively poor beard,
pubic and axillary hair development, gynecomastia,
stretched penile length of 14 cm, small testes and normal
intelligence (Table 1).
He was treated with human chorionic gonadotropin for six
months and with clomiphene citrate in another clinic nine
years ago. He had bilateral mastectomy eight years ago.
Abdominal pelvic ultrasonography (USG) showed atrophic
seminal vesicles and prostate and no mullerian derivatives.
Microscopic testicular sperm extraction (TESE) was per-
formed. Testicular biopsies were taken from four different
parts of the testes. After mechanical separation of seminifer-
ous tubules, microscopic examination revealed no live or
dead spermatozoa. Histopathological examination revealed
an apparent thickening of the basal membrane and only
Sertoli cells. There were no spermatogenetic cells inside the
lumen of seminiferous tubules. Extensively hyalinised
seminiferous tubules were present, consistent with a
Sertoli-cell-only syndrome (Fig. 1).
Patient II
Patient II was a 16-year-old male admitted to the Urology
Clinic with complaints of having small testes and penis.
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He was the second child of healthy parents. He has a 19 year
old healthy brother. Past medical history was unremarkable
with respect to probable risk factors such as trauma, medi-
cation, radiation, infection, or chemical exposure. He was
born after a normal pregnancy period and delivery. His
birth weight was 3,700 g and he reached puberty at the age
of 15. At admission, his height was 152 cm (-3 SD). He
had a normal scrotum and a stretched penile length of
12.5 cm (Marshall & Tanner stage 2) [Marshall and
Tanner 1970]. Testicular volume was 6 ml on the left and
right and a vas deferens was palpable bilaterally. Testosterone
replacement treatment with depot testosterone undecanoate
was started due to hypogonadism. Table I presents the
clinical findings of both patients.
Results and Discussion
Chromosomal analysis using GTG-banding revealed a 46,XX
karyotype (450 bands of resolution) and both patients were
diagnosed as XX males. PCR analysis showed amplification
of sY1532, SRY, and ZFY genes that are located on the
short arm of the Y chromosome (Fig. 2, Table 2). None of
the tested AZFa, AZFb, and AZFc sequences could be
detected. FISH analysis confirmed the presence of SRY trans-
located to the Xp region demonstrating a karyotype 46,XX. ish
(DXZ1x1)[6]/(DXZ1x2,SRYx1)[243]/(DXZ1x3,SRYx2)[4] for
patient I, and 46,XX.ish der(X)t(X;Y)(p22.3;p11.3)(SRY+)
for patient II (Fig. 3, Table 2). Methylation analysis of the
AR gene of both cases demonstrated random X chromosome
inactivation (XCI) (53%:47% and 59%:41% skewing, respect-
ively) in peripheral blood sample and 59% in testicular tissue
in patient I (Fig. 4).
In this study, we describe the clinical, cytogenetic, and
molecular features of two males with SRY-positive 46,XX tes-
ticular DSD. Both cases have the appearance of classical 46,
XX, SRY positive male phenotypic features, namely,
Table 1. Clinical findings of patients.
Patient I Patient II
Age 30 16
Height (cm) 155 152
Body weight (kg) 70 65
Body mass index (kg/m2) 27.3 22.5
Paternal consanguinity Third degree -
Secondary sexual characteristics Marshall & Tanner stage 3 Marshall & Tanner stage 2
Age of pubertal onset 14 15
Clinical Features
Bitesticular volume 4 cc on the left and 1 cc on the right 6 cc on the left and right
Palpable bilateral vas deferens + +




Ejaculation volume Low Normal
Penile length (cm) 14 12.5
Abdominal Pelvic USG Data
Prostate volume(cc) 10 Not investigated
Hormonal Profile Hypergonadotropic hypogonadism Hypergonadotropic hypogonadism
Endocrinological Data
FSH (mU/mL) 37.88 41.05
LH (mIU/mL) 18.96 14.55
Prolactin (ng/mL) 17.54 24.11
TT (ng/mL) 0.510 2.16
NR: 3.00-6.00 ng/mL NR: 3.00-10.00 ng/mL
E2 (pg/mL) 17.57 32.00
Semen analysis Azoospermia Azoospermia
Pathological Findings Sertoli-cell-only Not investigated
NR: normal range
Figure 1. Histopathological results of testis biopsies of patient 1. Tes-
ticular histology shows an apparent decrease of seminiferous tubules in
testicular parenchyma. Most of the seminiferous tubules show semini-
ferous tubule hyalinization and Sertoli-cells only syndrome with com-
plete absence of spermatogenetic cells (Haemotoxilin-eosin x400
magnification).
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azoospermia, decreased body height, and small testis. In com-
parison, some of 46,XX SRY-positive patients may present
cryptorchidism or can have genital ambiguities and can
even be true hermaphrodites. The variation of the phenotypic
features of the SRY positive 46,XXmalesmight be relatedwith
the length of the Y chromosomal material translocated on the
short arm of the X chromosome [Bouayed Abdelmoula et al.
2003; Kusz et al. 1999], X inactivation pattern [Bouayed Ab-
delmoula et al. 2003; Kusz et al. 1999; Boucekkine et al.
1985; Schempp et al. 1989], position effect [Sharp et al.
2005] or presence of another Y linked gene [Bouayed Abdel-
moula et al. 2003] whichmay have a role inmale sexual devel-
opment at the translocated segment.
Obligatory crossing over may take place between the X
and Y chromosomes at the pseudoautosomal regions
(PARs) during male meiosis. Along the non-recombining
region of the Y chromosome, there are regions that have
homology with the X chromosome but these regions do
not normally undergo recombination [McElreavey and
Cortes 2001]. The SRY gene encodes the ‘testis-determining
factor’ which is essential for the development of the male
during fetal life [Sinclair et al. 1990]. In some cases, a Y
chromosome fragment can be translocated to the X chromo-
some by an aberrant interchange between the X and the Y
chromosomes during paternal meiotic division [Ferguson-
Smith 1966; Margarit et al. 2000]. The reason for this trans-
location could be the homology existing between the two
homologous genes, PRKX and PRKY. The sequence simi-
larity between these genes is 94%. The PRKY gene is
approximately 7 Mb away from the obligatory recombina-
tion region, PAR1 [Weil et al. 1994; Schiebel et al. 1997].
As a result of that recombination, the individuals have
male sexual characteristics because of the presence of SRY
gene on the X chromosome despite the XX sex chromosome
pattern. The size of the translocated fragment is variable
between SRY-positive XX males [Sharp et al. 2005; Vergnaud
et al. 1986]. We did not determine in any of our cases the
length of the translocated fragment.
The presence of the SRY gene on Xp leads to normal male
sexual development. Though 46,XX testicular DSD patients
usually have normal external genitalia, sometimes hypospa-
dia or cryptorchidism may be seen [Yencilek and Baykal
2005]. Therefore, it is difficult to find 46,XX testicular
DSD males before puberty. Our cases had no sexual ambigu-
ities and were diagnosed after puberty [Wang et al. 2009].
Occasionally, SRY-positive XX males have sexual ambiguity
despite having the SRY gene depending on the amount of
material of Yp transferred to the X chromosome [Kusz
et al. 1999; Queipo et al. 2002].
In 46,XX testicular DSD patients, the level of testosterone
is normal during puberty but deficiency develops during
adulthood leading to hypergonadotropic hypogonadism. In
addition, infertility, and high levels of LH and FSH are
observed [Yencilek and Baykal 2005]. In patient II, the tes-
tosterone level was mildly suppressed and a further decrease
in the testosterone level is expected as presented in patient
I. Microscopic examination of both testes showed hyaliniza-
tion of most tubules in patient I without any spermatoge-
netic cells, consistent with, Sertoli-cell-only syndrome
[Bouayed Abdelmoula et al. 2003].
The XCI assay was used to determine whether preferen-
tial X-chromosome inactivation could be detected. Both
patients showed a random inactivation pattern. The
results of the XCI analysis in 46,XX testicular DSD patients
are controversial [Bouayed Abdelmoula et al. 2003; Kusz
et al. 1999; Boucekkine et al. 1985; Schempp et al. 1989;
Vorona et al. 2007]. Both random and nonrandom X
chromosome inactivation patterns have been reported. It
has been suggested that there is no apparent relationship
between phenotype and the pattern of X inactivation in
SRY-positive 46,XX male patients. Additionally, the
studied tissue can not fully represent all the tissues. Accord-
ing to our knowledge in most cases XCI analysis was per-
formed on peripheral blood. XCI analysis was performed
for both peripheral blood and testes for patient I to study
tissue-specific patterns of X inactivation. Our results re-
vealed that there is no preferential silencing of der(X;Y)
in peripheral blood and testes. Differences in the size of
the translocated fragment could lead to discrepancies of X
chromosome inactivation analysis [Allen et al. 1992;
Schempp et al. 1989; Queipo et al. 2002]. The length of
the Y chromosome fragment in 46,XX male patients
ranges from 40 kb to > 75% of the Yp. The phenotypic
differences could depend on the proximity of the break-
point to the SRY gene. The presence or absence of cryptic
Figure 2. Electrophoresis of the PCR products of SRY+ chromo-
somes. Line 1, positive control (male); line 2, marker (R322DNA/
BsuRI); line 3, SRY and ZFX/Y amplification of case I; line 4, SRY
and ZFX/Y amplification of case II; line 5, female control; line 6,
negative control.
Table 2. Chromosomal and molecular analysis.
Patient I Patient II
Karyotype 46,XX 46,XX
sY1532, SRY and ZFY genes +,+,+ (PB) and (T) +,+,+ (PB)
AZF regions - -
Degree of skewness %53 (PB), %59 (T) %59 (PB)
FISH
Patient I 46,XX. nuc ish(DXZ1x1)[6]/
(DXZ1x2,SRYx1)[243]/(DXZ1x3,
SRYx2)[4]
Patient II 46,XX.ish der(X)t(X;Y)(p22.3;
p11.3) (DXZ1x2)(SRY+)
PB: peripheral blood, T: testis
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recombinations may affect the expression of SRY gene by
position effect [Sharp et al. 2005].
Recently Chernykh and colleagues [2009] reported X
chromosomal mosaicism in a 37-year-old SRY positive 46,
XX male. Low grade mosaicism with three different cell
lines was detected in patient I. It has been suggested that
the presence of structurally normal and abnormal X
chromosomes predisposes one to mitotic nondisjunction
Figure 3. Fluorescence in situ hybridization (FISH) results. FISH analysis was performed on both interphase nuclei and metaphase spreads of
patient I and on metaphase spreads of patient II. A-B) Interphase cells: A) 3 copies of DXZ1 and 1 copy of sex-determining region Y (SRY) (on
top) and 2 copies of DXZ1 and 1 copy of SRY (on bottom), B) 2 copies of DXZ1 and 1 copy of SRY (on top) and only 1 copies of DXZ1 (on
bottom); C-E) Metaphase cells: C) 2 copies of DXZ1 and 1 copy of SRY, D) 3 copies of DXZ1 and 1 copy of SRY, and E) 2 copies of DXZ1 and
1 copy of SRY (patient II). DXZ1:
Cases of SRY-Positive 46,XX Testicular DSD 45































that can lead to X chromosomal mosaicism [Chernykh et al.
2009]. Abnormal mitotic segregation would be related with
advanced age and cause X chromosomal mosaicism [Ogata
et al. 2001] as it was in patient I.
In summary, we report two XX males with SRY gene at
the end of the short arm of chromosome X. Both presented
a classical phenotype and a normal XCI suggesting that
skewed X inactivation is not mandatory for the distinct clini-
cal signs of the disease.
Materials and Methods
Prior to the study, all patients were informed about
the investigation and a signed consent form was obtained.
All protocols involving the use of human tissue specimens
were approved by the Institutional Review Board.
Cytogenetic analysis
Chromosomal analyses of peripheral blood samples were
performed using standard procedures. Chromosome
banding was achieved by Giemsa (GTG) method described
in detail [Seabright 1971].
FISH analysis
FISH analysis was performed on both interphase nuclei and
metaphase spreads of patient I and only on metaphase
spreads of patient II (the supplement section contains
details on FISH analysis of a third patient). FISH was per-
formed on metaphase spreads and interphase nuclei of the
lymphocytes, according to the manufacturer’s instructions.
X centromere (CEP X) and SRY-specific (LSI SRY) probes,
(Vysis Inc., Downers Grove, IL, USA) were used.
Molecular analysis
The genomic DNA was isolated from peripheral venous
blood samples of the patients by the ‘salting out’ method
[Miller et al. 1988] and from testes using a commercially
available kit (Invitrogen Genomic DNA Mini Kit, Carlsbad,
CA, USA) according to the manufacturer’s instructions. In
addition to a negative control, normal male DNA and
normal female DNA were used as controls. SRY (sY14 and
sY1532), ZFY, sY84, sY86, sY127, sY134, sY254, sY255,
SMCY, and CDY2 locus amplification was performed using
multiplex PCR (Simoni et al. 2004; Nakashima et al. 2002).
The amplification products were resolved on 2% agarose
and analyzed using a video gel documentation system
(Biolabs, Kyoto, Japan) after staining with ethidium bromide.
X-chromosome inactivation analysis
DNA was isolated from blood sample of the patient using
Nucleospin Blood kit (Macharey-Nagel, Düren, Germany) as
in the protocol supplied by the manufacturer. X chromosome
inactivation (XCI) pattern of the patient is determined by
genotyping of the highly polymorphic CAG repeat in the
androgen receptor (AR) gene, known as XCI assay, as in the
protocol [Ozbalkan et al. 2005; Allen et al. 1992]. Briefly,
DNA was digested with methylation specific restriction
enzyme HpaII (MBI Fermentas, Vilnius, Lithuania), which
cleaves unmethylated (or active) X fragments. Therefore, the
methylated (or inactive) X chromosome remains intact for
PCR amplification. PCR products were separated on 8% dena-
turing 29:1 acrylamide:bisacrylamide gel for 4 h at constant
15W. MultiAnalyst version 1.1 software (Bio-Rad, Hercules,
California) was used for densitometric analysis of the alleles.
Testicular histology
Testicular biopsy was taken during microscopic TESE under
spinal anesthesia in the operating room. The specimen fixed
in Bouin’s solution was delivered to the pathology labora-
tory. Following the fixation, routine procedure was per-
formed and sections were stained with Haemotoxilin-eosin
(H&E) [Magid et al. 1990].
Declaration of interest: The authors report no conflict of
interest.
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Figure 4. X chromosome inactivation pattern of case I and case II. PCR products of undigested (U) and HpaII-digested (C) DNA from peripheral
blood and testis (Case 1). XCI patterns of the cases. Line 1, marker (pUCmix 8), 331, 242 and 190 bp fragments are visible; line 2 and 3: male control;
line 4 and 5, case I (PB); line 6 and 7, case I (T); 8 and 9 case II (PB); line 10 and 11, positive control. PB: Peripheral blood, T: Testis.
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Note of added Proof
The X chromosome inactivation (XCI) assay of a third
patient showed a non-random pattern of X chromosome
inactivation (Supplemental Fig. 1 – 4 and Supplemental
Tables I and II). As detailed in the Supplement we report
three XX males with SRY gene at the end of the short arm
of chromosome X. All patients presented a classical pheno-
type with normal and completely skewed XCI suggesting
that skewed X inactivation is not mandatory for the distinct
clinical signs of the disease.
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